Sai Life SciencesNSE:SAILIFE -0.47%18 Pretax Margin % is 23.12% as of Mar. 2026, which is 208% above its 10-year median of 7.50. GuruFocus rates NSE:SAILIFE with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Sai Life Sciences ranks better than 90.1% on this metric.
The historical rank and industry rank for Sai Life Sciences's Pretax Margin % or its related term are showing as below:
NSE:SAILIFE'
s Pretax Margin % Range Over the Past 10 Years
Min: 1.12 Med: 7.5 Max: 21.26
Current: 21.26
NSE:SAILIFE's Pretax Margin % is ranked better than 90.1% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.565
vs NSE:SAILIFE: 21.26
Sai Life Sciences (NSE:SAILIFE) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Sai Life Sciences Pretax Margin % Related Terms
Sai Life Sciences Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Sai Life Sciences's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SAILIFE vs TMO, DHR, IDXX: Pretax Margin % Comparison
For the Diagnostics & Research subindustry, Sai Life Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sai Life Sciences Pretax Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sai Life Sciences's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Sai Life Sciences's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sai Life Sciences (NSE:SAILIFE) has a Pretax Margin % of 23.12% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sai Life Sciences and its competitors. This is 208% above median its historical median of 7.50. Over the past decade, Sai Life Sciences' Pretax Margin % has ranged from 1.12 to 21.26. According to the industry distribution chart, Sai Life Sciences ranks #20 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 9.9%.
Is Sai Life Sciences' Pretax Margin % too high?
Sai Life Sciences' current Pretax Margin % of 23.12% is 208% above median its 10-year median of 7.50. Over the past 10 years, this metric has ranged from a low of 1.12 to a high of 21.26. Based on the distribution chart, Sai Life Sciences ranks #20 out of 202 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Sai Life Sciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sai Life Sciences' Pretax Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Sai Life Sciences ranks #20 out of 202 companies for Pretax Margin %. This places Sai Life Sciences in the top 10% of its industry — outperforming the majority of peers. Historically, Sai Life Sciences' own Pretax Margin % has ranged from 1.12 to 21.26 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Diagnostics & Research company?
A good Pretax Margin % depends on the Medical Diagnostics & Research industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sai Life Sciences and its competitors. Sai Life Sciences's current Pretax Margin % is 23.12%, which is 208% above median its own 10-year median of 7.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Life Sciences stock overvalued right now?
Sai Life Sciences (NSE:SAILIFE) has a current Pretax Margin % of 23.12%. The current Pretax Margin % is 23.12%, which is 208% above median its 10-year median of 7.50. Sai Life Sciences' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Sai Life Sciences (NSE:SAILIFE), the current Pretax Margin % is 23.12% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
18GF Score
Get the complete analysis for NSE:SAILIFE
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAILIFE has been successfully added to your 
